Common Contracts
3 similar Agreement of Merger contracts by Taro Pharmaceutical Industries LTD, Sun Pharmaceutical Industries LTD
AGREEMENT OF MERGERAgreement of Merger • January 17th, 2024 • Taro Pharmaceutical Industries LTD • Pharmaceutical preparations
This Agreement of Merger is made and entered into as of January 17, 2024 by and among Sun Pharmaceutical Industries Ltd., a corporation organized under the laws of India (“Parent”), Alkaloida Chemical Company ZRT (f/k/a Alkaloida Chemical Company Exclusive Group Limited) (“Alkaloida”), a corporation organized under the laws of Hungary and under the control of Parent, The Taro Development Corporation, a corporation organized under the laws of New York and under the control of Parent (“TDC”), Sun Pharma Holdings, a corporation organized under the laws of Mauritius and a direct wholly owned subsidiary of Parent (“SPH”), Libra Merger Ltd., an Israeli company under the control of Parent and a direct wholly owned subsidiary of Alkaloida, TDC and SPH (“Merger Sub”), and Taro Pharmaceutical Industries Ltd., an Israeli company (the “Company”). Certain capitalized terms used but not defined in this Agreement are defined in Exhibit A hereto.
AGREEMENT OF MERGERAgreement of Merger • January 17th, 2024 • Sun Pharmaceutical Industries LTD • Pharmaceutical preparations
This Agreement of Merger is made and entered into as of January 17, 2024 by and among Sun Pharmaceutical Industries Ltd., a corporation organized under the laws of India (“Parent”), Alkaloida Chemical Company ZRT (f/k/a Alkaloida Chemical Company Exclusive Group Limited) (“Alkaloida”), a corporation organized under the laws of Hungary and under the control of Parent, The Taro Development Corporation, a corporation organized under the laws of New York and under the control of Parent (“TDC”), Sun Pharma Holdings, a corporation organized under the laws of Mauritius and a direct wholly owned subsidiary of Parent (“SPH”), Libra Merger Ltd., an Israeli company under the control of Parent and a direct wholly owned subsidiary of Alkaloida, TDC and SPH (“Merger Sub”), and Taro Pharmaceutical Industries Ltd., an Israeli company (the “Company”). Certain capitalized terms used but not defined in this Agreement are defined in Exhibit A hereto.
AGREEMENT OF MERGERAgreement of Merger • August 13th, 2012 • Taro Pharmaceutical Industries LTD • Pharmaceutical preparations
This Agreement of Merger is made and entered into as of August 12, 2012 by and among Sun Pharmaceutical Industries Limited, a corporation organized under the laws of India (“Parent”), Alkaloida Chemical Company Exclusive Group Limited (“Alkaloida”), a corporation organized under the laws of Hungary and under the control of Parent, Aditya Acquisition Company Ltd., an Israeli company under the control of Parent and a direct wholly owned subsidiary of Alkaloida (“Merger Sub”), and Taro Pharmaceutical Industries Ltd., an Israeli company (the “Company”). Certain capitalized terms used but not defined in this Agreement are defined in Exhibit A hereto.
